C-B-D Becomes F.D.A. Approved AKA Mainstream?

Share Button

“If the agency (F.D.A.) follows the recommendation, as is expected, the drug would be the first cannabis-derived prescription medicine available in the United States…”

The article linked and excerpted below has nothing to do with cancer but everything to do with the Food and Drug Administration aka the F.D.A.. I’m writing a post about the article because:

  1. Cannabidiol aka CBD oil is being discussed like an average F.D.A. approved therapy-
  2. The more cannabinoids show medical efficacy the more difficult it is for the federal government to outlaw medical marijuana-
  3. Readers of the New York Times will become more knowledgeable about cannabis

I am in no way endorsing GW Pharmaceuticals or Epidiolex. I know very little about CBD and epilepsy. I do, however, know that research has established CBD as a pain management therapy and I do know that CBD can work synergistically with certain cancer chemotherapy regimens. Most importantly, CBD may be cancer killing.

I believe that the U.S is missing a huge oppotunity by not researching, by not learning more about cannabinoids and their medical applications toward cancer, pain management or epilepsy.

But in my view, the fact that the F.D.A. is reviewing a cannabinoid-based therapy is progress.

Do you have cancer? If you would like to learn more about CBD and cancer, scroll down the page, post a question or comment and I will reply to you ASAP.

Thank you,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

Recommended Reading:


“A cannabinoid is one of a class of diverse chemical compounds that acts on cannabinoid receptors in cells that alter neurotransmitter release in the brain. Ligands for these receptor proteins include the endocannabinoids (produced naturally in the body by animals),[1] the phytocannabinoids (found in cannabis and some other plants), and synthetic cannabinoids (manufactured artificially). The most notable cannabinoid is the phytocannabinoid tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis.[2][3] Cannabidiol (CBD) is another major constituent of the plant.[4] There are at least 113 different cannabinoids isolated from cannabis, exhibiting varied effects.[5]…”

F.D.A. Panel Recommends Approval of Cannabis-Based Drug for Epilepsy

“A Food and Drug Administration advisory panel on Thursday unanimously recommended approval of an epilepsy medication made with an ingredient found in marijuana. If the agency follows the recommendation, as is expected, the drug would be the first cannabis-derived prescription medicine available in the United States.

The drug, called Epidiolex, is made by GW Pharmaceuticals, a British company. Its active ingredient, cannabidiol, also called CBD, is one of the chemical compounds found in the cannabis plant, but it does not contain the properties that make people high.

That makes it different from the “medical marijuana” allowed by a growing number of states. In those cases, certain patients are legally authorized to smoke or ingest marijuana to treat severe pain, nausea and other ailments…

There are already several drugs on the market that are derived from synthetic versions of THC and other chemicals of the cannabis plant, generally used to ease nausea in cancer patients, and to help AIDS patients avoid weight loss…

“This is a very good development, and it basically underscores that there are medicinal properties to some of the cannabinoids,”…“I think there could well be other cannabinoids that are of therapeutic use, but there is just not enough research on them to say…”

The briefing materials prepared for the committee by F.D.A. staff made it clear that the agency supports the application. The F.D.A. wrote that GW Pharma had submitted positive results of efficacy from three randomized, double-blind, placebo-controlled trials conducted in patients with both diseases.

“The statistically significant and clinically meaningful results from these three studies provide substantial evidence of the effectiveness of CBD for the treatment of seizures associated with LGS and DS,” the agency noted….”

Leave a Comment:

Add Your Reply